Stem Cell Therapy for Inherited Retinal Disorders: Rebuilding the Retina
Listen to this summary
The authors investigate the potential of stem cell therapy as a treatment for inherited retinal disorders (IRDs), which lead to progressive vision loss due to photoreceptor and retinal pigment epithelium degeneration. They highlight recent advancements in clinical trials that show the safety of various administration methods for stem cell therapies, while emphasizing the need for larger studies to assess the efficacy of these treatments in preventing or reversing vision loss.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from American journal of ophthalmology
View all →Aug 5, 2026 · American journal of ophthalmology
Neighborhood Socioeconomic Deprivation and Adherence to Diabetic Retinopathy Screening Guidelines
Aug 5, 2026 · American journal of ophthalmology
No-History IOL Power Calculation After Myopic Laser Vision Correction: A Multicenter Retrospective Database Study of 14 Formulas With and Without Posterior Corneal Curvature
Aug 4, 2026 · American journal of ophthalmology
Optical coherence tomography-guided focal navigated laser photocoagulation in central serous chorioretinopathy: a non-inferiority study
Aug 4, 2026 · American journal of ophthalmology
In Vivo Microscopic Assessment of Ocular Surface Changes Induced by Antiglaucoma Medications
Aug 4, 2026 · American journal of ophthalmology
Factors associated with delays in the diagnosis of childhood onset uveitis: findings from a nation-wide cohort study
Aug 3, 2026 · American journal of ophthalmology
Refining How We Diagnose and Classify Limbal Stem Cell deficiency
More in Ophthalmology
View all →Aug 6, 2026 · Lancet (London, England)
[<sup>177</sup>Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
Aug 5, 2026 · The New England journal of medicine
Syncope
Jul 31, 2026 · Journal of cataract and refractive surgery
Aberration-guided Intraocular Lens Power Calculation in Keratoconus: Ray Tracing Optimization
Jul 31, 2026 · Lancet (London, England)
Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial
Jul 30, 2026 · Lancet (London, England)
Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial
Jul 30, 2026 · Lancet (London, England)
Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
